T H 2 and T H 17 inflammatory pathways are reciprocally regulated in asthma
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Increasing evidence suggests that asthma is a heterogeneous disorder regulated by distinct molecular mechanisms. In a cross-sectional study of asthmatics of varying severity (n = 51), endobronchial tissue gene expression analysis revealed three major patient clusters: TH2-high, TH17-high, and TH2/17-low. TH2-high and TH17-high patterns were mutually exclusive in individual patient samples, and their gene signatures were inversely correlated and differentially regulated by interleukin-13 (IL-13) and IL-17A. To understand this dichotomous pattern of T helper 2 (TH2) and TH17 signatures, we investigated the potential of type 2 cytokine suppression in promoting TH17 responses in a preclinical model of allergen-induced asthma. Neutralization of IL-4 and/or IL-13 resulted in increased TH17 cells and neutrophilic inflammation in the lung. However, neutralization of IL-13 and IL-17 protected mice from eosinophilia, mucus hyperplasia, and airway hyperreactivity and abolished the neutrophilic inflammation, suggesting that combination therapies targeting both pathways may maximize therapeutic efficacy across a patient population comprising both TH2 and TH17 endotypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The data summarized above suggest that targeting JAK and STAT3 with small-molecule inhibitors may provide a superior anti-asthma treatment approach compared with standard therapies as, they would target both Th2- and Th17-associated asthmas (Choy et al., 2015).”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Choy et al., 2015
In the citing paper
“almost all murine models of intestinal fibrosis are influenced by the microbiota154”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [154]
Citations
Cites
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R., & Program, G. I. F. A. (. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00526.x · Cited by 3,529
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
British Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,021
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871 · cited 1×
“Identifying the molecular mechanisms driving subtypes of asthma has the potential to reveal drug targets, biomarkers to predict treatment response, and appropriately target therapy, as evidenced by recent clinical studies of T helper 2 (TH2) cytokine antagonists (8, 9).”
BackgroundSelf-citationThe development of allergic inflammation
Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008) · Nature · doi:10.1038/nature07204 · Cited by 1,839
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803 · cited 6×
“SERPINB2, CLCA1, and POSTN were used as IL-13–responsive TH2 signature genes as described previously (25, 26).”
BackgroundMethodInfluentialSelf-citationAsthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Self-citationLebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Self-citationTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Interleukin-17 and Type 17 Helper T Cells
Miossec, P., Korn, T., & Kuchroo, V. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0707449 · Cited by 1,409
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.ats9-00 · Cited by 909
Zurawski, G., & de Vries, J. E. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90021-3 · Cited by 872
Bradding, P., Roberts, J. A., Britten, K. M., Montefort, S., Djukanovic, R., Mueller, R., Heusser, C. H., Howarth, P. H., & Holgate, S. T. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.5.8179909 · Cited by 830
Self-citationWoodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828 · cited 1×
“1) (42), elevated serum periostin levels predict clinical benefit from IL-13 inhibition (9), and serum periostin concentrations in anti-IL-13–treated moderate-severe asthma patients fall to levels observed in healthy nonasthmatic subjects (32).”
BackgroundEvidence of a Role of Tumor Necrosis Factor α in Refractory Asthma
Berry, M. A., Hargadon, B., Shelley, M., Parker, D., Shaw, D. E., Green, R. H., Bradding, P., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa050580 · Cited by 826
Self-citationTH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice
McKinley, L., Alcorn, J. F., Peterson, A., DuPont, R. B., Kapadia, S., Logar, A., Henry, A., Irvin, C. G., Piganelli, J. D., Ray, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4089 · Cited by 777 · cited 8×
“Mice treated with either anti–IL-13 alone or anti–IL-13 + anti–IL-17 had significantly reduced AHR and mucus response relative to control antibody–treated animals or anti–IL-17 alone (Fig.”
BackgroundInfluentialIndependent filtering increases detection power for high-throughput experiments
Bourgon, R., Gentleman, R., & Huber, W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914005107 · Cited by 740
Cytokines in symptomatic asthma airways
Broide, D. H., Lotz, M., Cuomo, A. J., Coburn, D. A., Federman, E. C., & Wasserman, S. I. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90218-q · Cited by 736
Busse, W. W., Holgate, S., Kerwin, E., Chon, Y., Feng, J., Lin, J., & Lin, S.-L. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2318oc · Cited by 666
Bradley, B. L., Azzawi, M., Jacobson, M., Assoufi, B., Collins, J. V., Irani, A.-M. A., Schwartz, L. B., Durham, S. R., Jeffery, P. K., & Kay, A. B. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90160-p · Cited by 665
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Jia, G., Erickson, R. W., Choy, D. F., Mosesova, S., Wu, L. C., Solberg, O. D., Shikotra, A., Carter, R., Audusseau, S., Hamid, Q., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.025 · Cited by 615
Self-citationIL-13 receptors and signaling pathways: An evolving web
Hershey, G. K. K. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1333 · Cited by 610
Interleukin 4 is localized to and released by human mast cells.
Bradding, P., Feather, I. H., Howarth, P. H., Mueller, R., Roberts, J. A., Britten, K., Bews, J. P., Hunt, T. C., Okayama, Y., & Heusser, C. H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1381 · Cited by 573
Self-citationHowarth, P. H. (2005) · Thorax · doi:10.1136/thx.2005.045260 · Cited by 495
Berry, M., Morgan, A., Shaw, D. E., Parker, D., Green, R., Brightling, C., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2007) · Thorax · doi:10.1136/thx.2006.073429 · Cited by 483
Self-citationImmunologic messenger molecules: Cytokines, interferons, and chemokines
Commins, S. P., Borish, L., & Steinke, J. W. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.008 · Cited by 479
A Large Subgroup of Mild-to-Moderate Asthma Is Persistently Noneosinophilic
McGrath, K. W., Icitovic, N., Boushey, H. A., Lazarus, S. C., Sutherland, E. R., Chinchilli, V. M., & Fahy, J. V. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1640oc · Cited by 478
Wang, Y.-H., Voo, K. S., Liu, B., Chen, C.-Y., Uygungil, B., Spoede, W., Bernstein, J. A., Huston, D. P., & Liu, Y.-J. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101376 · Cited by 431
British Thoracic Society guidelines on diagnostic flexible bronchoscopy
British Thoracic Society Bronchoscopy Guidelines Committee, A. S. O. T. S. O. C. C. O. T. B. T. S. (2001) · Thorax · doi:10.1136/thx.56.suppl_1.i1 · Cited by 402
Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine
BARCZYK, A., PIERZCHALA, W., & SOZAÑSKA, E. (2003) · Respiratory Medicine · doi:10.1053/rmed.2003.1507 · Cited by 363
Fajt, M. L., & Wenzel, S. E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1871 · Cited by 353
Bhattacharya, D., Aldus, C. F., Barton, G., Bond, C. M., Boonyaprapa, S., Charles, I. S., Fleetcroft, R., Holland, R., Jerosch‐Herold, C., Salter, C., et al. (2016) · Cited by 339
Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
Shikotra, A., Choy, D. F., Ohri, C. M., Doran, E., Butler, C., Hargadon, B., Shelley, M., Abbas, A. R., Austin, C. D., Jackman, J., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.08.031 · Cited by 333
Self-citationTh17-mediated inflammation in asthma
Newcomb, D. C., & Peebles, R. S. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.08.002 · Cited by 315
Wenzel, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1181pp · Cited by 309 · cited 1×
“Asthma causes significant morbidity and mortality (1–4), and about 10% of patients have disease that is resistant to current therapies (1, 4).”
BackgroundCosmi, L., Maggi, L., Santarlasci, V., Capone, M., Cardilicchia, E., Frosali, F., Querci, V., Angeli, R., Matucci, A., Fambrini, M., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.012 · Cited by 302
Calhoun, W. J., Dick, E. C., Schwartz, L. B., & Busse, W. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117581 · Cited by 300
TILLIE-LEBLOND, I., PUGIN, J., MARQUETTE, C.-H., LAMBLIN, C., SAULNIER, F., BRICHET, A., WALLAERT, B., TONNEL, A.-B., & GOSSET, P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.2.9805115 · Cited by 259
Liu, Y.-J. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.004 · Cited by 258
TNFα mRNA expression in allergic inflammation
YING, S., ROBINSON, D. S., VARNEY, V., MENG, Q., TSICOPOULOS, A., MOQBEL, R., DURHAM, S. R., KAY, A. B., & HAMID, Q. (1991) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1991.tb03205.x · Cited by 199
Nanzer, A. M., Chambers, E. S., Ryanna, K., Richards, D. F., Black, C., Timms, P. M., Martineau, A. R., Griffiths, C. J., Corrigan, C. J., & Hawrylowicz, C. M. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.037 · Cited by 181
Severe asthma: Advances in current management and future therapy
Barnes, P. J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.11.006 · Cited by 174
Chiaramonte, M. G., Cheever, A. W., Malley, J. D., Donaldson, D. D., & Wynn, T. A. (2001) · Hepatology · doi:10.1053/jhep.2001.26376 · Cited by 174
Self-citationInterleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
Zijlstra, G. J., ten Hacken, N. H. T., Hoffmann, R. F., van Oosterhout, A. J. M., & Heijink, I. H. (2012) · European Respiratory Journal · doi:10.1183/09031936.00017911 · Cited by 170
Fischer, J. A. A., Hueber, A. J., Wilson, S., Galm, M., Baum, W., Kitson, C., Auer, J., Lorenz, S. H., Moelleken, J., Bader, M., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.38896 · Cited by 162
Gene Expression Patterns of Th2 Inflammation and Intercellular Communication in Asthmatic Airways
Choy, D. F., Modrek, B., Abbas, A. R., Kummerfeld, S., Clark, H. F., Wu, L. C., Fedorowicz, G., Modrusan, Z., Fahy, J. V., Woodruff, P. G., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002568 · Cited by 161
Self-citationGoleva, E., Hauk, P. J., Hall, C. F., Liu, A. H., Riches, D. W. H., Martin, R. J., & Leung, D. Y. M. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.07.007 · Cited by 157
Airway hyperresponsiveness is dissociated from airway wall structural remodeling
Siddiqui, S., Mistry, V., Doe, C., Roach, K. M., Morgan, A. J., Wardlaw, A. J., Pavord, I. D., Bradding, P., & Brightling, C. E. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.05.020 · Cited by 134
Self-citationCellular Infiltration of the Airways in Asthma of Varying Severity
Synek, M., Beasley, R. W., Frew, A. J., Goulding, D., Holloway, L., Lampe, F. C., Roche, W. R., & Holgate, S. T. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.1.8680684 · Cited by 134
Choy, D. F., Hsu, D. K., Seshasayee, D., Fung, M. A., Modrusan, Z. D., Martin, F., Liu, F., & Arron, J. R. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.044 · Cited by 132
Self-citationAsthma: prevalence and cost of illness
Stock, S., Redaèlli, M., Lüngen, M., Wendland, G., Civello, D., & Lauterbach, K. W. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00116203 · Cited by 124
Opposing roles for IL‐13 and IL‐13 receptor α2 in health and disease
Mentink‐Kane, M. M., & Wynn, T. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00210.x · Cited by 117
Self-citationColobrán, R., Pujol‐Borrell, R., Armengol, M. P., & Juan, M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03344.x · Cited by 109 · cited 1×
“Because the TH17 signature genes include potent neutrophil chemoattractants (29, 30), we hypothesized that TH17 signature expression in patients would relate to measures of neutrophilic airway inflammation, as we described previously for inflammatory dermatoses (49).”
BackgroundHuman TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production
Newcomb, D. C., Boswell, M. G., Zhou, W., Huckabee, M. M., Goleniewska, K., Sevin, C. M., Hershey, G. K. K., Kolls, J. K., & Peebles, R. S. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.043 · Cited by 108 · cited 3×
“TH2 cytokines can negatively regulate TH17 cytokine expression, and inhibiting TH2 cytokines in vitro or in vivo has the potential to increase IL-17A production and IL-17A–dependent airway inflammation (23, 24).”
BackgroundResultInfluentialGupta, A. K., Dimeloe, S., Richards, D. F., Chambers, E. S., Black, C., Urry, Z., Ryanna, K., Xystrakis, E., Bush, A., Saglani, S., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203421 · Cited by 105
IL-13 Regulates Th17 Secretion of IL-17A in an IL-10–Dependent Manner
Newcomb, D. C., Boswell, M. G., Huckabee, M. M., Goleniewska, K., Dulek, D. E., Reiss, S., Lukacs, N. W., Kolls, J. K., & Peebles, R. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102216 · Cited by 98
Glucocorticoid receptor β and histone deacetylase 1 and 2 expression in the airways of severe asthma
Butler, C. A., McQuaid, S., Taggart, C. C., Weldon, S., Carter, R., Skibiński, G., Warke, T. J., Choy, D. F., McGarvey, L. P., Bradding, P., et al. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200760 · Cited by 77 · cited 1×
“Patients and assessments Patients were recruited from two centers, Leicester and Belfast, and their clinical data and tissues have been used in previously published studies (27, 60).”
MethodSelf-citationA qPCR‐based metric of Th2 airway inflammation in asthma
Bhakta, N. R., Solberg, O. D., Nguyen, C. P., Nguyen, C. N., Arron, J. R., Fahy, J. V., & Woodruff, P. G. (2013) · Clinical and Translational Allergy · doi:10.1186/2045-7022-3-24 · Cited by 73
Self-citationNoninvasive Biomarkers That Predict Treatment Benefit from Biologic Therapies in Asthma
Arron, J. R., Choy, D. F., Scheerens, H., & Matthews, J. G. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201303-047aw · Cited by 72
Self-citationMucosal inflammation in severe glucocorticoid-dependent asthma
Vrugt, B., Wilson, S. J., Underwood, J., Bron, A., de Bruyn, R., Bradding, P., Holgate, S., Djukanović, R., & Aalbers, R. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.13612539 · Cited by 42
Self-citationTNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction
Badalyan, V., Thompson, R., Addo, K., Borthwick, L. A., Fisher, A. J., Ort, T., Myers, T. G., Wynn, T. A., & Ramalingam, T. R. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.019 · Cited by 40
Self-citationRedefining Approaches to Asthma
Arron, J. R., Scheerens, H., & Matthews, J. G. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-404717-4.00001-9 · Cited by 30
Self-citation
Cited by
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Self-citationPapi, A., Brightling, C., Pedersen, S. E., & Reddel, H. K. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33311-1 · Cited by 1,759
Inflammation and metabolism in tissue repair and regeneration
Eming, S. A., Wynn, T. A., & Martin, P. (2017) · Science · doi:10.1126/science.aam7928 · Cited by 1,369
Self-citationThe basic immunology of asthma
Hammad, H., & Lambrecht, B. N. (2021) · Cell · doi:10.1016/j.cell.2021.02.016 · Cited by 1,105
Lambrecht, B. N., Hammad, H., & Fahy, J. V. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.018 · Cited by 1,039
Metadata
- Authors
- Choy, D. F., Hart, K. M., Borthwick, L. A., Shikotra, A., Nagarkar, D. R., Siddiqui, S., Jia, G., Ohri, C. M., Doran, E., Vannella, K. M., Butler, C. A., Hargadon, B., Sciurba, J. C., Gieseck, R. L., Thompson, R. W., White, S., Abbas, A. R., Jackman, J., Wu, L. C., Egen, J. G., Heaney, L. G., Ramalingam, T. R., Arron, J. R., Wynn, T. A., & Bradding, P.
- Affiliations
- Genentech (US)
- National Institutes of Health (US)
- Newcastle University (GB)
- University of Leicester (GB)
- Queen's University Belfast (GB)
- Corresponding author
- Choy, David F.
- Hart, Kevin M.
- Arron, Joseph R.
- Wynn, Thomas A.
- Bradding, Peter
- ORCID
- Choy, David F.
- Hart, Kevin M.
- Borthwick, Lee A.
- Nagarkar, Deepti R.
- Siddiqui, Salman
- Jia, Guiquan
- Doran, Emma
- Vannella, Kevin M.
- Butler, Claire A.
- Hargadon, Beverley
- Sciurba, Joshua C.
- Gieseck, Richard L.
- Abbas, Alexander R.
- Jackman, Janet
- Egen, Jackson G.
- Heaney, Liam G.
- Ramalingam, Thirumalai R.
- Arron, Joseph R.
- Wynn, Thomas A.
- Bradding, Peter
- Venue
- Science Translational Medicine
- Published
- 2015-08-19
- Volume
- 7
- Issue
- 301
- Pages
- 301ra129-301ra129
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2166997969
- Cited by
- 450
- References
- 63
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 26 · 2023: 34 · 2022: 41 · 2021: 42 · 2020: 71 · 2019: 46 · 2018: 48 · 2017: 46 · 2016: 48 · 2015: 5
- FWCI
- 36.11
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Funders
- NIH
- NIAID
- Genentech Inc.
- National Institute for Health Research
- Asthma UK (AUK-PG-2013-208)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- asthma, type 2 inflammation, Th17 inflammation, IL-13, IL-17A, IL-4, asthma endotypes, neutrophilic inflammation, eosinophilia, airway hyperresponsiveness, allergic asthma, combination therapy, cytokine neutralization
- MeSH terms
- Animals, Asthma, Cells, Cultured, Female, Humans, Mice, Inbred BALB C, Signal Transduction, Th2 Cells, Interleukin-13, Interleukin-17, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.